Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.
Majidova N, Aghamaliyeva S, Guliyev M, Dinc G, Akyıldız A, Ozcan E, Akdağ Kahvecıoglu F, Çağrı Yıldırım H, Sever N, Guren AK, Kocaaslan E, Erel P, Agyol Y, Celebi A, Arıkan R, Isık S, Bayoglu IV, Demirci NS, Dizdar Ö, Hacıbekiroğlu I, Kostek O, Sarı M. Majidova N, et al. Among authors: kostek o. J Chemother. 2024 Nov 26:1-6. doi: 10.1080/1120009X.2024.2430845. Online ahead of print. J Chemother. 2024. PMID: 39588941
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy.
Ilhan Y, Ucar G, Baser MN, Guzel HG, Efil SC, Demir B, Ercan Uzundal D, Karacelik T, Sever N, Balcik OY, Arvas H, Karadag I, Kadioglu A, Ekinci ÖB, Karacin C, Urakci Z, Kostek O, Karakurt Eryilmaz M, Yazici O, Sendur MAN, Ozturk B, Uncu D, Ergun Y. Ilhan Y, et al. Among authors: kostek o. Expert Opin Pharmacother. 2024 Aug;25(11):1555-1563. doi: 10.1080/14656566.2024.2391007. Epub 2024 Aug 11. Expert Opin Pharmacother. 2024. PMID: 39115275
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.
Majidova N, Seyyar M, Bayraktar DI, Dinç G, İsgandarov E, Huseynov J, Yaşar A, Çelebi A, Sever N, Kocaaslan E, Erel P, Ağyol Y, Güren AK, Arıkan R, Işık S, Ercelep Ö, Demirağ G, Kefeli U, Köstek O, Bayoğlu İV, Sarı M. Majidova N, et al. Among authors: kostek o. Biomol Biomed. 2024 Oct 17;24(6):1776-1784. doi: 10.17305/bb.2024.10512. Biomol Biomed. 2024. PMID: 38920621 Free PMC article.
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arıkan R, Isık S, Balvan O, Geredelı C, Uygun K, Hacibekiroglu I, Kostek O, Bayoglu IV. Majidova N, et al. Among authors: kostek o. Oncol Res Treat. 2024;47(7-8):360-367. doi: 10.1159/000537988. Epub 2024 Apr 2. Oncol Res Treat. 2024. PMID: 38565096 Free article.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Kahraman S, Karakaya S, Kaplan MA, Goksu SS, Ozturk A, Isleyen ZS, Hamdard J, Yildirim S, Dogan T, Isik S, Celebi A, Gulbagci BB, Paksoy N, Dogan M, Turk HM, Bilici A, Tatli AM, Akbas S, Turan N, Hacibekiroglu I, Dogu GG, Aydiner A, Sumbul AT, Akyurek S, Yalciner M, Demirkazik A, Gursoy P, Aykan MB, Sahin E, Karadag İ, Kostek O, Er MM, Artaç M, Duzkopru Y, Aydin D, Isik D, Karakas Y, Kilickap S, Erol C, Demir B, Civelek B, Ergun Y, Akinci MB, Dogan I, Karadurmus N, Yumuk PF, Sendur MAN. Kahraman S, et al. Among authors: kostek o. Sci Rep. 2024 Mar 9;14(1):5820. doi: 10.1038/s41598-024-56046-w. Sci Rep. 2024. PMID: 38461209 Free PMC article.
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
Köstek O, Demirel A, Hacıoğlu MB, Tastekin D, Karabulut S, Gündogdu A, Sever N, Ayhan M, Çelebi A, Majidova N, Yaşar A, Ağyol Y, Erel P, Kocaaslan E, Güren AK, Arıkan R, Isık S, Ercelep O, Goksu SS, Alandag C, Bilgetekin İ, Caner B, Sahin AB, Gulmez A, Akagunduz B, Kose F, Kaplan MA, Dogan E, Sakalar T, Guven DC, Gurbuz M, Ergun Y, Karaagac M, Turker S, Ozkul O, Yıldız B, Sahin S, Demiray AG, Sari M, Erdogan B, Hacıbekiroglu İ, Çakmak Öksüzoğlu ÖB, Kilickap S, Bilici A, Bayoglu İV, Topaloglu S, Cicin İ. Köstek O, et al. J Chemother. 2024 Nov;36(7):613-621. doi: 10.1080/1120009X.2024.2305066. Epub 2024 Jan 23. J Chemother. 2024. PMID: 38263804
Evaluating therapeutic efficacy of extended shelf-life 90 Y glass microspheres in transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT analysis.
Kesim S, Balaban Genc ZC, Soydemir E, Baltacioglu F, Kissa TN, Ozdemir B, Ozguven S, Filizoglu N, Niftaliyeva K, Engur CO, Kostek O, Akdeniz E, Turoglu HT, Erdil TY, Cimsit C, Ones T. Kesim S, et al. Among authors: kostek o. Nucl Med Commun. 2024 Apr 1;45(4):268-277. doi: 10.1097/MNM.0000000000001813. Epub 2024 Jan 12. Nucl Med Commun. 2024. PMID: 38214074
96 results